Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection.
Oramed has an experienced management team with many years of business and pharmaceutical experience, and is backed by world-class scientific experts.
